Royal Bank of Canada
CMPI

Royal Bank of Canada’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Royal Bank of Canada’s Portfolio CMPI Stock Details CMPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-168
Closed – – 8261
2021
Q4 		$0 Hold
168
– – ﹤0.01% 8190
2021
Q3 		$1K Sell
168
-2,219
-93% -$11.4K ﹤0.01% 7569
2021
Q2 		$14K Buy
2,387
+1,364
+133% +$9.64K ﹤0.01% 6759
2021
Q1 		$12K Buy
1,023
+687
+204% +$9.77K ﹤0.01% 6742
2020
Q4 		$5K Buy
+336
New +$4.28K ﹤0.01% 6694

Other funds holding CMPI

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Royal Bank of Canada's CMPI Position: Q1 2022 in Review

Royal Bank of Canada sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q1 2022, closing a stake of 168 shares.

Royal Bank of Canada first reported a position in CMPI in Q4 2020 and held it in 5 quarters. The position peaked at $14K in Q2 2021. 26 funds tracked by Wall St. Rank hold CMPI as of Q1 2022.

  • Royal Bank of Canada reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 168 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q1 2022.
  • Royal Bank of Canada first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Royal Bank of Canada's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $14K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.